Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

University Of Minnesota
Sponsor

University Of Minnesota

United States 2221 University Avenue Southeast Suite 200, 55414-3075, United States

About the sponsor

Clinical research activity centers on COVID-19 treatment in both hospitalized adults and outpatient populations, with attention to improving clinical status and recovery during active infection.

  • Antiviral therapy
  • Anti-coronavirus immunoglobulin
  • Standard of care combination treatment

Studies include interventions intended to address acute SARS-CoV-2 infection across different care settings.

About Specializations

University Of Minnesota runs clinical trials in conditions such as COVID-19, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

COVID-19

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anti-Sars-Cov-2 Polyclonal Hyperimmune Globulin
  • Sponsor:University Of Minnesota

COVID-19

Not recruiting
Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:University Of Minnesota

COVID-19

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:(6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
  • Sponsor:University Of Minnesota

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.